✦ LIBER ✦

A phase I study with MAG-camptothecin intravenously administered weekly for 3 weeks in a 4-week cycle in adult patients with solid tumours

✍ Scribed by Wachters, F M; Groen, H J M; Maring, J G; Gietema, J A; Porro, M; Dumez, H; de Vries, E G E; van Oosterom, A T

Book ID: 109998058
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 117 KB
Volume: 90
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6601811

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I study of bendamustine hydrochl

A phase I study of bendamustine hydrochloride administered day 1+2 every 3 weeks in patients with solid tumours

✍ Rasschaert, M; Schrijvers, D; Van den Brande, J; Dyck, J; Bosmans, J; Merkle, K; 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

Phase I study of cisplatin, irinotecan,

Phase I study of cisplatin, irinotecan, and epirubicin administered every 3 weeks in patients with advanced solid tumours

✍ Chen, X; Oza, A M; Kusenda, Z; Yi, Q-L; Kochman, D; Moore, M J; Davis, A J; Siu, 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 127 KB

A phase I study of recombinant interfero

A phase I study of recombinant interferon gamma administered by s.c. injection three times per week in patients with solid tumours

✍ John Wagstaff; David Smith; Philipp Nelmes; Peter Loynds; Derek Crowther 📂 Article 📅 1987 🏛 Springer-Verlag 🌐 English ⚖ 479 KB

Human recombinant DNA interferon gamma (IFN-G), with a specific activity of 2 x 10 6 I U / m g protein, was administered s.c. 3 days per week for 2 months to patients with solid tumors. The maximum tolerated dose (MTD) was 10 × 10 6 I U / m 2 (5.0 mg/m 2) per injection, and six patients were treated

Phase I and pharmacokinetic study of XR1

Phase I and pharmacokinetic study of XR11576, an oral topoisomerase I and II inhibitor, administered on days 1–5 of a 3-weekly cycle in patients with advanced solid tumours

✍ de Jonge, M J A; Kaye, S; Verweij, J; Brock, C; Reade, S; Scurr, M; van Doorn, L 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 127 KB

Phase I/II study of a 3-week cycle of ir

Phase I/II study of a 3-week cycle of irinotecan and S-1 in patients with advanced colorectal cancer

✍ Hitoshi Kusaba; Taito Esaki; Kitaro Futami; Sinnosuke Tanaka; Hiromitsu Fujishim 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB

Phase I study to evaluate multiple regim

Phase I study to evaluate multiple regimens of intravenous 5-fluorouracil administered in combination with weekly gemcitabine in patients with advanced solid tumors : A potential broadly active regimen for advanced solid tumor malignancies

✍ Sridhar Mani; Nicholas J. Vogelzang; Donna Bertucci; Walter M. Stadler; Richard 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views